Letter to the Editor
Cell Death and Differentiation (2004) 11, 583–587. doi:10.1038/sj.cdd.4401388 Published online 30 January 2004
Targeting Bcl-xL in esophageal squamous cancer to sensitize to chemotherapy plus TRAIL-induced apoptosis while normal epithelial cells are protected by blockade of caspase 9
K Kim1,2,3,4,5,7, H Nakagawa2,5,6, P Fei1,2,3,4,5, A K Rustgi2,3,5,6 and W S El-Deiry1,2,3,4,5
- 1Laboratory of Molecular Oncology and Cell Cycle Regulation, Howard Hughes Medical Institute, Philadelphia, PA, USA
- 2Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
- 3Department Genetics, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
- 4Departments of Pharmacology, and Abramson Cancer Center, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
- 5Abramson Cancer Center, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
- 6Division of Gastroenterology, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
- 7Current address: Department of Biochemistry and Molecular Biology, Yonsei University College of Medicine, Seoul, Korea
Correspondence: WS El-Deiry, University of Pennsylvania School of Medicine, 415 Curie Blvd., CRB 437A, Philadelphia, PA 19104, USA. Tel: +1 215 898 9015; Fax: +1 215 573 9139; E-mail: wafik@mail.med.upenn.edu
Top of page
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
RESEARCH
Structure of the Mad2 spindle assembly checkpoint protein and its interaction with Cdc20
Nature Structural Biology Article (01 Mar 2000)
Cancer Gene Therapy Original Article
Oncogene Original Article
Molecular Therapy Original Article
